Number of times cited according to CrossRef:

Magdalena Cerdá, William R. Ponicki, Nathan Smith, Ariadne Rivera-Aguirre, Corey S. Davis, Brandon D.L. Marshall, David S. Fink, Stephen G. Henry, Alvaro Castillo-Carniglia, Garen J. Wintemute, Andrew Gaidus, Paul J. Gruenewald, Silvia S. Martins, Measuring Relationships Between Proactive Reporting State-level Prescription Drug Monitoring Programs and County-level Fatal Prescription Opioid Overdoses, Epidemiology, 10.1097/EDE.0000000000001123, 31, 1, (32-42),

Keith Humphreys, Harold A. Pollack, How Should the United States Respond to the Opioid Addiction and Overdose Epidemic?, The Palgrave Handbook of American Mental Health Policy, 10.1007/978-3-030-11908-9, (259-295),

Bahareh Ansari, Katherine M. Tote, Eli S. Rosenberg, Erika G. Martin, A Rapid Review of the Impact of Systems-Level Policies and Interventions on Population-Level Outcomes Related to the Opioid Epidemic, United States and Canada, 2014-2018, Public Health Reports, 10.1177/0033354920922975, 135, 1_suppl, (100S-127S),

Fahd Alogaili, Norjihan Abdul Ghani, Nordiana Ahmad Kharman Shah, Prescription drug monitoring programs in the US: A systematic literature review on its strength and weakness, Journal of Infection and Public Health, 10.1016/j.jiph.2020.06.035,

Sean Grant, Rosanna Smart, Bradley D. Stein, We Need a Taxonomy of State-Level Opioid Policies, JAMA Health Forum, 10.1001/jamahealthforum.2020.0050, 1, 2, (e200050),

Tom May, Katy Holloway, Marian Buhociu, Rhian Hills, Not what the doctor ordered: Motivations for nonmedical prescription drug use among people who use illegal drugs, International Journal of Drug Policy, 10.1016/j.drugpo.2020.102823, 82, (102823),

Le Foll, undefined Bernard, Opioid-sparing effects of cannabinoids: Myth or reality?, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 10.1016/j.pnpbp.2020.110065, (110065),

Robert Nadeau, Kristopher Hasstedt, Ashley Brooke Sunstrum, Chad Wagner, Harold Tu, Addressing the Opioid Epidemic: Impact of Opioid Prescribing Protocol at the University of Minnesota School of Dentistry, Craniomaxillofacial Trauma & Reconstruction, 10.1055/s-0038-1649498, 11, 2, (104-110),

Srikant Devaraj, Pankaj C. Patel, Michael J. Hicks, Must access laws for opioid prescription and county gross domestic product: evidence from the US, Applied Economics Letters, 10.1080/13504851.2020.1740155, (1-5),

Nicole Adams, Ellen Gundlach, Ching-Wei Cheng, An Analysis of State-Level Policies and Opioid Overdose Deaths, Western Journal of Nursing Research, 10.1177/0193945919897538, (019394591989753),

Rosanna Smart, Bryce Pardo, Corey S. Davis, Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States, Addiction, 10.1111/add.15163, 0, 0,

Deborah S. Hasin, Dvora Shmulewitz, Magdalena Cerdá, Katherine M. Keyes, Mark Olfson, Aaron L. Sarvet, Melanie M. Wall, U.S. Adults With Pain, A Group Increasingly Vulnerable to Nonmedical Cannabis Use and Cannabis Use Disorder: 2001–2002 and 2012–2013, American Journal of Psychiatry, 10.1176/appi.ajp.2019.19030284, (appi.ajp.2019.1),

Aaron Dora-Laskey, Jason Goldstick, Brooke Arterberry, Suni Roberts, Rebecca Haffajee, Amy Bohnert, Rebecca Cunningham, Patrick Carter, Prevalence and Predictors of Driving after Prescription Opioid Use in an Adult ED Sample, Western Journal of Emergency Medicine, 10.5811/westjem.2020.3.44844, 21, 4,

Rose Cairns, Andrea L. Schaffer, Jared A. Brown, Sallie‐Anne Pearson, Nicholas A. Buckley, Codeine use and harms in Australia: evaluating the effects of re‐scheduling, Addiction, 10.1111/add.14798, 115, 3, (451-459),

Hsien-Chang Lin, Zhi Wang, Linda Simoni-Wastila, Carol Boyd, Anne Buu, Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain, Preventive Medicine, 10.1016/j.ypmed.2018.10.011, 118, (59-65),

Aylin N. Bilgutay, Hannah Hua, Mary Edmond, Emily S. Blum, Edwin A. Smith, James M. Elmore, Hal C. Scherz, Michael Garcia-Roig, Andrew J. Kirsch, Wolfgang H. Cerwinka, Opioid Utilization is Minimal after Outpatient Pediatric Urologic Surgery, Journal of Pediatric Urology, 10.1016/j.jpurol.2019.10.021,

Patience Moyo, Linda Simoni‐Wastila, Beth Ann Griffin, Donna Harrington, G. Caleb Alexander, Francis Palumbo, Eberechukwu Onukwugha, Prescription drug monitoring programs: Assessing the association between “best practices” and opioid use in Medicare, Health Services Research, 10.1111/1475-6773.13197, 54, 5, (1045-1054),

Danielle N. Atkins, Christine Piette Durrance, Yuna Kim, Good Samaritan harm reduction policy and drug overdose deaths, Health Services Research, 10.1111/1475-6773.13119, 54, 2, (407-416),

Tamara M. Haegerich, Christopher M. Jones, Pierre-Olivier Cote, Amber Robinson, Lindsey Ross, Evidence for state, community and systems-level prevention strategies to address the opioid crisis, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2019.107563, (107563),

Judith A. Paice, Pain in Cancer Survivors: How to Manage, Current Treatment Options in Oncology, 10.1007/s11864-019-0647-0, 20, 6,

Ji-Yeun Park, Li-Tzy Wu, Trends and correlates of driving under the influence of alcohol among different types of adult substance users in the United States: a national survey study, BMC Public Health, 10.1186/s12889-019-6889-8, 19, 1,

Enihomo Obadan-Udoh, Nicoleta Lupulescu-Mann, Christina J. Charlesworth, Ulrike Muench, Matthew Jura, Hyunjee Kim, Eli Schwarz, Elizabeth Mertz, Benjamin C. Sun, Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015, The Journal of the American Dental Association, 10.1016/j.adaj.2018.12.030, 150, 4, (259-268.e1),

Alvaro Castillo-Carniglia, William R. Ponicki, Andrew Gaidus, Paul J. Gruenewald, Brandon D. L. Marshall, David S. Fink, Silvia S. Martins, Ariadne Rivera-Aguirre, Garen J. Wintemute, Magdalena Cerdá, Prescription Drug Monitoring Programs and Opioid Overdoses, Epidemiology, 10.1097/EDE.0000000000000950, 30, 2, (212-220),

Barbara St. Marie, Assessing Patients’ Risk for Opioid Use Disorder, AACN Advanced Critical Care, 10.4037/aacnacc2019931, 30, 4, (343-352),

Matthew Salzman, Christopher W. Jones, Rachel Rafeq, John Gaughan, Rachel Haroz, Epidemiology of opioid-related visits to US Emergency Departments, 1999–2013: A retrospective study from the NHAMCS (National Hospital Ambulatory Medical Care Survey), The American Journal of Emergency Medicine, 10.1016/j.ajem.2019.03.052,

Joseph R. Hsu, Hassan Mir, Meghan K. Wally, Rachel B. Seymour, Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury, Journal of Orthopaedic Trauma, 10.1097/BOT.0000000000001430, 33, 5, (e158-e182),

Judith A. Paice, Risk Assessment and Monitoring of Patients with Cancer Receiving Opioid Therapy, The Oncologist, 10.1634/theoncologist.2019-0301, 24, 10, (1294-1298),

Justine Mallatt, Unintended Consequences of Prescription Monitoring: Policy-Induced Substitution to Illicit Drugs, SSRN Electronic Journal, 10.2139/ssrn.3418615,

Chihua Li, Julian Santaella-Tenorio, Pia M. Mauro, Silvia S. Martins, Past-year use of prescription opioids and/or benzodiazepines among adults in the United States: Estimating medical and nonmedical use in 2015-2016, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2019.04.029,

Sheree Pagsuyoin, Jiayue Luo, Jana Latayan, undefined, 2019 Systems and Information Engineering Design Symposium (SIEDS), 10.1109/SIEDS.2019.8735614, (1-5),

Matthew J. Witry, Barbara J. St. Marie, Brahmendra Reddy Viyyuri, Paul D. Windschitl, Factors Influencing Judgments to Consult Prescription Monitoring Programs: A Factorial Survey Experiment, Pain Management Nursing, 10.1016/j.pmn.2019.04.001,

Gail K. Strickler, Kun Zhang, John M. Halpin, Amy S.B. Bohnert, Grant Baldwin, Peter W. Kreiner, Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2019.02.010,

Qiushi Chen, Marc R. Larochelle, Davis T. Weaver, Anna P. Lietz, Peter P. Mueller, Sarah Mercaldo, Sarah E. Wakeman, Kenneth A. Freedberg, Tiana J. Raphel, Amy B. Knudsen, Pari V. Pandharipande, Jagpreet Chhatwal, Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the United States, JAMA Network Open, 10.1001/jamanetworkopen.2018.7621, 2, 2, (e187621),

Walter Ling, Vijay R. Nadipelli, Naoko A. Ronquest, Victoria A. Albright, Arnie P. Aldridge, Susan M. Learned, Vishaal Mehra, Christian Heidbreder, Remission from chronic opioid use—Studying environmental and socio-economic factors on recovery (RECOVER): Study design and participant characteristics, Contemporary Clinical Trials, 10.1016/j.cct.2018.11.015, 76, (93-103),

Rosanna Smart, Courtney A. Kase, Erin A. Taylor, Bradley D. Stein, Strengths and Weaknesses of Existing Data Sources to Support Research to Address the Opioids Crisis, Preventive Medicine Reports, 10.1016/j.pmedr.2019.101015, (101015),

Theodore J. Cicero, Matthew S. Ellis, Zachary A. Kasper, Polysubstance Use: A Broader Understanding of Substance Use During the Opioid Crisis, American Journal of Public Health, 10.2105/AJPH.2019.305412, (e1-e7),

Devon Meadowcroft, Brian Whitacre, Do prescription drug monitoring programs encourage prescription – or illicit – opioid abuse?, Substance Abuse, 10.1080/08897077.2019.1695707, (1-11),

Rahi Abouk, Rosalie Liccardo Pacula, David Powell, Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose, JAMA Internal Medicine, 10.1001/jamainternmed.2019.0272,

Ali B. Abbasi, Elizabeth Salisbury-Afshar, Dejan Jovanov, Craig Berberet, Ponni Arunkumar, Steven E. Aks, Jennifer E. Layden, Mai T. Pho, Health Care Utilization of Opioid Overdose Decedents with No Opioid Analgesic Prescription History, Journal of Urban Health, 10.1007/s11524-018-00329-x,

Meda Raghavendra, Can Blockchain technologies help tackle the opioid epidemic: A Narrative Review, Pain Medicine, 10.1093/pm/pny315,

Gabrielle Campbell, Emily Stockings, Suzanne Nielsen, Understanding the evidence for medical cannabis and cannabis-based medicines for the treatment of chronic non-cancer pain, European Archives of Psychiatry and Clinical Neuroscience, 10.1007/s00406-018-0960-9,

Nathan Smith, Silvia S. Martins, June Kim, Ariadne Rivera‐Aguirre, David S. Fink, Alvaro Castillo‐Carniglia, Stephen G. Henry, Stephen J. Mooney, Brandon D. L. Marshall, Corey Davis, Magdalena Cerdá, A typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016, Addiction, 10.1111/add.14440, 114, 2, (248-258),

Stefan G. Kertesz, Adam J. Gordon, A crisis of opioids and the limits of prescription control: United States, Addiction, 10.1111/add.14394, 114, 1, (169-180),

R. Vincent Pohl, Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality, SSRN Electronic Journal, 10.2139/ssrn.3192703,

Bradley R. Ray, Evan M. Lowder, Aaron J. Kivisto, Peter Phalen, Harold Gil, EMS naloxone administration as non‐fatal opioid overdose surveillance: 6‐year outcomes in Marion County, Indiana, Addiction, 10.1111/add.14426, 113, 12, (2271-2279),

Di Liang, Yuhua Bao, Mark Wallace, Igor Grant, Yuyan Shi, Medical cannabis legalization and opioid prescriptions: evidence on US Medicaid enrollees during 1993–2014, Addiction, 10.1111/add.14382, 113, 11, (2060-2070),

Wayne Hall, Robert West, John Marsden, Keith Humphreys, Joanne Neale, Nancy Petry, It is premature to expand access to medicinal cannabis in hopes of solving the US opioid crisis, Addiction, 10.1111/add.14139, 113, 6, (987-988),

Bryce Pardo, Peter Reuter, Narcotics and Drug Abuse, Criminology & Public Policy, 10.1111/1745-9133.12363, 17, 2, (419-436),

Judith A. Paice, Cancer pain management and the opioid crisis in America: How to preserve hard‐earned gains in improving the quality of cancer pain management, Cancer, 10.1002/cncr.31303, 124, 12, (2491-2497),

Mark Borgschulte, Adriana Corredor-Waldron, Guillermo Marshall, A Path Out: Prescription Drug Abuse, Treatment, and Suicide, SSRN Electronic Journal, 10.2139/ssrn.2847121,

Rachel L. Goldberg, Janine K. Cataldo, Marijuana and Prescription Pain Reliever Use among Cigarette Smokers, Journal of Psychoactive Drugs, 10.1080/02791072.2018.1506598, 50, 4, (339-347),

Maya A Babu, Brian V Nahed, Robert F Heary, Commentary: Prescription Drug Monitoring Programs and the Neurosurgeon: Impact on Workflow and Overall Perceptions, Neurosurgery, 10.1093/neuros/nyy314, 83, 4, (E169-E176),

Rebecca L. Haffajee, Michelle M. Mello, Fang Zhang, Alan M. Zaslavsky, Marc R. Larochelle, J. Frank Wharam, Four States With Robust Prescription Drug Monitoring Programs Reduced Opioid Dosages, Health Affairs, 10.1377/hlthaff.2017.1321, 37, 6, (964-974),

Timothy E. Hereford, Kipp A. Cryar, Paul K. Edwards, Eric R. Siegel, C. Lowry Barnes, Simon C. Mears, Patients With Hip or Knee Arthritis Underreport Narcotic Usage, The Journal of Arthroplasty, 10.1016/j.arth.2018.05.032, 33, 10, (3113-3117),

Allison L. Pitt, Keith Humphreys, Margaret L. Brandeau, Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic, American Journal of Public Health, 10.2105/AJPH.2018.304590, 108, 10, (1394-1400),

Sarah J. Nechuta, Benjamin D. Tyndall, Sutapa Mukhopadhyay, Melissa L. McPheeters, Sociodemographic factors, prescription history and opioid overdose deaths: a statewide analysis using linked PDMP and mortality data, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2018.05.004, 190, (62-71),

Adam J. Rose, Dana Bernson, Kenneth Kwan Ho Chui, Thomas Land, Alexander Y. Walley, Marc R. LaRochelle, Bradley D. Stein, Thomas J. Stopka, Potentially Inappropriate Opioid Prescribing, Overdose, and Mortality in Massachusetts, 2011–2015, Journal of General Internal Medicine, 10.1007/s11606-018-4532-5, 33, 9, (1512-1519),

Thomas R. Radomski, Felicia R. Bixler, Susan L. Zickmund, KatieLynn M. Roman, Carolyn T. Thorpe, Jennifer A. Hale, Florentina E. Sileanu, Leslie R. M. Hausmann, Joshua M. Thorpe, Katie J. Suda, Kevin T. Stroupe, Adam J. Gordon, Chester B. Good, Michael J. Fine, Walid F. Gellad, Physicians’ Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study, Journal of General Internal Medicine, 10.1007/s11606-018-4374-1, 33, 8, (1253-1259),

John Matthew Butler, William C. Becker, Keith Humphreys, Big Data and the Opioid Crisis: Balancing Patient Privacy with Public Health, The Journal of Law, Medicine & Ethics, 10.1177/1073110518782952, 46, 2, (440-453),

Mark Borgschulte, Adriana Corredor-Waldron, Guillermo Marshall, A path out: Prescription drug abuse, treatment, and suicide, Journal of Economic Behavior & Organization, 10.1016/j.jebo.2018.03.006, 149, (169-184),

David Powell, Rosalie Liccardo Pacula, Mireille Jacobson, Do medical marijuana laws reduce addictions and deaths related to pain killers?, Journal of Health Economics, 10.1016/j.jhealeco.2017.12.007, 58, (29-42),

Corey S. Davis, Amy Judd Lieberman, Hector Hernandez-Delgado, Carli Suba, Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A National Systematic Legal Review, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2018.09.022,

Yuhua Bao, Katherine Wen, Phyllis Johnson, Philip J. Jeng, Zachary F. Meisel, Bruce R. Schackman, Assessing The Impact Of State Policies For Prescription Drug Monitoring Programs On High-Risk Opioid Prescriptions, Health Affairs, 10.1377/hlthaff.2018.0512, 37, 10, (1596-1604),

Richard A. Deyo, Sara E. Hallvik, Christi Hildebran, Miguel Marino, Rachel Springer, Jessica M. Irvine, Nicole O'Kane, Joshua Van Otterloo, Dagan A. Wright, Gillian Leichtling, Lisa M. Millet, Jody Carson, Wayne Wakeland, Dennis McCarty, Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers, The Journal of Pain, 10.1016/j.jpain.2017.10.001, 19, 2, (166-177),

N.J. Pauly, S. Slavova, C. Delcher, P.R. Freeman, J. Talbert, Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings, Drug and Alcohol Dependence, 10.1016/j.drugalcdep.2017.12.002, 184, (26-32),

Benjamin C. Sun, Christina J. Charlesworth, Nicoleta Lupulescu-Mann, Jenny I. Young, Hyunjee Kim, Daniel M. Hartung, Richard A. Deyo, K. John McConnell, Effect of Automated Prescription Drug Monitoring Program Queries on Emergency Department Opioid Prescribing, Annals of Emergency Medicine, 10.1016/j.annemergmed.2017.10.023, 71, 3, (337-347.e6),

David S. Fink, Julia P. Schleimer, Aaron Sarvet, Kiran K. Grover, Chris Delcher, Alvaro Castillo-Carniglia, June H. Kim, Ariadne E. Rivera-Aguirre, Stephen G. Henry, Silvia S. Martins, Magdalena Cerdá, Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses, Annals of Internal Medicine, 10.7326/M17-3074, 168, 11, (783),

Gabrielle Campbell, Wayne Hall, Suzanne Nielsen, What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review, International Review of Psychiatry, 10.1080/09540261.2018.1509842, (1-16),

Kathryn Hawk, Gail D'Onofrio, David A. Fiellin, Marek C. Chawarski, Patrick G. O'Connor, Patricia H. Owens, Michael V. Pantalon, Steven L. Bernstein, Past‐year Prescription Drug Monitoring Program Opioid Prescriptions and Self‐reported Opioid Use in an Emergency Department Population With Opioid Use Disorder, Academic Emergency Medicine, 10.1111/acem.13352, 25, 5, (508-516),

Deborah S Hasin, US Epidemiology of Cannabis Use and Associated Problems, Neuropsychopharmacology, 10.1038/npp.2017.198, 43, 1, (195-212),

Scott Burris, Where Next for Opioids and the Law? Despair, Harm Reduction, Lawsuits, and Regulatory Reform, Public Health Reports, 10.1177/0033354917743500, 133, 1, (29-33),